Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein

被引:113
作者
Zouki, C [1 ]
Beauchamp, M [1 ]
Baron, C [1 ]
Filep, JG [1 ]
机构
[1] UNIV MONTREAL, HOP MAISON NEUVE ROSEMONT, RES CTR, DEPT MED, MONTREAL, PQ H1T 2M4, CANADA
关键词
C-reactive protein; adhesion molecules; L-selectin; neutrophils; inflammation;
D O I
10.1172/JCI119561
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
C-Reactive protein (CRP), the classic acute-phase reactant in humans, diminishes accumulation of neutrophils at inflammatory sites, To evaluate the underlying mechanisms, we have studied whether CRP and peptides derived from CRP could affect the first step of neutrophil extravasation, the L-selectin-mediated interaction of neutrophils with endothelial cells, CRP markedly attenuated attachment of human neutrophils to cultured LPS-activated human coronary artery and pulmonary microvascular endothelial cells with apparent IC50 values of 20 and 22 mu g/ml, respectively, At similar concentrations, CRP rapidly downregulated the expression of L-selectin on the neutrophil surface, whereas it failed to affect expression of CD11b and CD45 or to induce granule enzyme release, The loss of L-selectin was due to cleavage and shedding of the molecule from the cell surface, as quantitated by the soluble form of L-selectin in cell-free supernatants, The effects of CRP could be prevented by an anti-CRP antiserum and by KD-IX-73-4, which inhibits shedding of L-selectin. Inhibition of adhesion with CRP was additive with function-blocking anti-E-selectin and anti-CD18 antibodies, but was not additive with anti-L-selectin antibody, Neutrophil attachment and L-selectin expression were also diminished by CRP peptides 174-185 and 201-206, but not peptide 77-82, albeit these peptides showed a weaker inhibitory effect than the parent protein, These studies indicate a specific activation-independent action of CRP and CRP peptides 174-185 and 201-206 on expression of L-selectin, and suggest that by attenuating neutrophil adhesion to the endothelium and consequently neutrophil traffic into tissues, native CRP and peptides 174-185 and 201-206 may be major mechanisms to attenuate or limit the inflammatory response.
引用
收藏
页码:522 / 529
页数:8
相关论文
共 40 条
[1]   Transgenic mice expressing rabbit C-Reactive protein exhibit diminished chemotactic factor-induced alveolitis [J].
Ahmed, N ;
Thorley, R ;
Xia, DY ;
Samols, D ;
Webster, RO .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) :1141-1147
[2]   THERAPEUTIC EFFECTS OF A SYNTHETIC PEPTIDE OF C-REACTIVE PROTEIN IN PRECLINICAL TUMOR-MODELS [J].
BARNA, BP ;
EPPSTEIN, DA ;
THOMASSEN, MJ ;
NESTOR, JJ ;
HO, T ;
MEDENDORP, SV ;
DEODHAR, SD .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (03) :171-176
[3]   Activation of alveolar macrophage TNF and MCP-1 expression in vivo by a synthetic peptide of C-reactive protein [J].
Barna, BP ;
Thomassen, MJ ;
Zhou, P ;
Pettay, J ;
SinghBurgess, S ;
Deodhar, SD .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (03) :397-402
[4]  
BERG M, 1990, BLOOD, V76, P2381
[5]   BINDING OF C-REACTIVE PROTEIN TO HUMAN-NEUTROPHILS [J].
BUCHTA, R ;
PONTET, M ;
FRIDKIN, M .
FEBS LETTERS, 1987, 211 (02) :165-168
[6]   LEUKOCYTE-ENDOTHELIAL CELL RECOGNITION - 3 (OR MORE) STEPS TO SPECIFICITY AND DIVERSITY [J].
BUTCHER, EC .
CELL, 1991, 67 (06) :1033-1036
[7]   STRUCTURAL REQUIREMENTS REGULATE ENDOPROTEOLYTIC RELEASE OF THE L-SELECTIN (CD62L) ADHESION RECEPTOR FROM THE CELL-SURFACE OF LEUKOCYTES [J].
CHEN, AJ ;
ENGEL, P ;
TEDDER, TF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :519-530
[8]   RELEASE OF GELATINASE FROM A NOVEL SECRETORY COMPARTMENT OF HUMAN-NEUTROPHILS [J].
DEWALD, B ;
BRETZ, U ;
BAGGIOLINI, M .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (03) :518-525
[9]   PREVENTION OF IN-VITRO NEUTROPHIL-ENDOTHELIAL ATTACHMENT THROUGH SHEDDING OF L-SELECTIN BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
DIAZGONZALEZ, F ;
GONZALEZALVARO, I ;
CAMPANERO, MR ;
MOLLINEDO, F ;
DELPOZO, MA ;
MUNOZ, C ;
PIVEL, JP ;
SANCHEZMADRID, F .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1756-1765
[10]  
DUCLOS TW, 1981, CLIN EXP IMMUNOL, V43, P565